BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15217829)

  • 1. VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis.
    Le Gouill S; Podar K; Amiot M; Hideshima T; Chauhan D; Ishitsuka K; Kumar S; Raje N; Richardson PG; Harousseau JL; Anderson KC
    Blood; 2004 Nov; 104(9):2886-92. PubMed ID: 15217829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells.
    Gomez-Bougie P; Bataille R; Amiot M
    Eur J Immunol; 2004 Nov; 34(11):3156-64. PubMed ID: 15459900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokineticin-1/endocrine gland-derived vascular endothelial growth factor is a survival factor for human multiple myeloma cells.
    Li QF; Zhu HY; Yang YF; Liu J; Xiao FJ; Zhang QW; Wu CT; Wang H; Wang LS
    Leuk Lymphoma; 2010 Oct; 51(10):1902-12. PubMed ID: 20795791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
    Podar K; Gouill SL; Zhang J; Opferman JT; Zorn E; Tai YT; Hideshima T; Amiot M; Chauhan D; Harousseau JL; Anderson KC
    Oncogene; 2008 Jan; 27(6):721-31. PubMed ID: 17653083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.
    MacCallum DE; Melville J; Frame S; Watt K; Anderson S; Gianella-Borradori A; Lane DP; Green SR
    Cancer Res; 2005 Jun; 65(12):5399-407. PubMed ID: 15958589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironment.
    Podar K; Catley LP; Tai YT; Shringarpure R; Carvalho P; Hayashi T; Burger R; Schlossman RL; Richardson PG; Pandite LN; Kumar R; Hideshima T; Chauhan D; Anderson KC
    Blood; 2004 May; 103(9):3474-9. PubMed ID: 14644994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.
    Derenne S; Monia B; Dean NM; Taylor JK; Rapp MJ; Harousseau JL; Bataille R; Amiot M
    Blood; 2002 Jul; 100(1):194-9. PubMed ID: 12070027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma.
    Raje N; Kumar S; Hideshima T; Roccaro A; Ishitsuka K; Yasui H; Shiraishi N; Chauhan D; Munshi NC; Green SR; Anderson KC
    Blood; 2005 Aug; 106(3):1042-7. PubMed ID: 15827128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1.
    Cavarretta IT; Neuwirt H; Untergasser G; Moser PL; Zaki MH; Steiner H; Rumpold H; Fuchs D; Hobisch A; Nemeth JA; Culig Z
    Oncogene; 2007 May; 26(20):2822-32. PubMed ID: 17072336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.
    Puthier D; Derenne S; Barillé S; Moreau P; Harousseau JL; Bataille R; Amiot M
    Br J Haematol; 1999 Nov; 107(2):392-5. PubMed ID: 10583232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid cell factor-1 is a critical survival factor for multiple myeloma.
    Zhang B; Gojo I; Fenton RG
    Blood; 2002 Mar; 99(6):1885-93. PubMed ID: 11877256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulation.
    Fan F; Tonon G; Bashari MH; Vallet S; Antonini E; Goldschmidt H; Schulze-Bergkamen H; Opferman JT; Sattler M; Anderson KC; Jäger D; Podar K
    Cancer Lett; 2014 Feb; 343(2):286-94. PubMed ID: 24120758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation, and Mcl-1 elimination.
    Gómez-Benito M; Marzo I; Anel A; Naval J
    Mol Pharmacol; 2005 Jun; 67(6):1991-8. PubMed ID: 15738311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of vascular endothelial growth factor on apoptosis and expression of Bcl-2 and Mcl-1 in acute leukemia cells].
    Liao XL; Xie XT; Li BS; Li L; Yang LL
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):491-5. PubMed ID: 17178043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor.
    Muto A; Hori M; Sasaki Y; Saitoh A; Yasuda I; Maekawa T; Uchida T; Asakura K; Nakazato T; Kaneda T; Kizaki M; Ikeda Y; Yoshida T
    Mol Cancer Ther; 2007 Mar; 6(3):987-94. PubMed ID: 17363492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma.
    Gupta VA; Matulis SM; Conage-Pough JE; Nooka AK; Kaufman JL; Lonial S; Boise LH
    Blood; 2017 Apr; 129(14):1969-1979. PubMed ID: 28151428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
    Asano J; Nakano A; Oda A; Amou H; Hiasa M; Takeuchi K; Miki H; Nakamura S; Harada T; Fujii S; Kagawa K; Endo I; Yata K; Sakai A; Ozaki S; Matsumoto T; Abe M
    Leukemia; 2011 Jul; 25(7):1182-8. PubMed ID: 21475253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1.
    Song L; Li Y; Sun YX; Yu M; Shen BF
    Ai Zheng; 2002 Feb; 21(2):113-6. PubMed ID: 12479056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.
    Kobayashi S; Werneburg NW; Bronk SF; Kaufmann SH; Gores GJ
    Gastroenterology; 2005 Jun; 128(7):2054-65. PubMed ID: 15940637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.